Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

TA-270 inhibits the immediate and late asthmatic response and blocks DTH in animal studies

Aug. 19, 1998

SynPhar's HLE inhibitors show unique potential in preventing lung injury

Aug. 18, 1998

Two new series of PDE4 inhibitors reported by Byk Gulden

Aug. 18, 1998

Schering-Plough patents new tachykinin NK1/NK2 antagonists

Aug. 14, 1998

More PDE IVA inhibitors in the pipeline at Kyowa Hakko

Aug. 13, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Antiinflammatory cytokine modulators described by Amgen

Aug. 12, 1998

Kyowa Hakko discovers PDE IVA inhibitors for a range of potential indications

Aug. 12, 1998

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Aug. 11, 1998

Byk Gulden researchers synthesize PDE IV inhibitors with broad therapeutic potential

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...